Medicare Enrolled

Dr. Bruno Bastos, M.D.

Hematology & Oncology · Miami Beach, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
4306 ALTON RD FL 3, Miami Beach, FL 33140
3055353300
Registered in NPPES since 2007
NPI: 1619178936 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bastos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bastos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bastos

Dr. Bruno Bastos is a hematology & oncology specialist in Miami Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bastos performed 577 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Bastos received a total of $127,038 from 48 pharmaceutical and/or device companies across 205 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bastos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 577 Medicare services $127,038 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 105209 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
577
Medicare services
Bottom 43% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
380 $78 $309
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
95 $102 $379
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
46 $122 $454
New patient office visit, complex (60-74 min) 22 $155 $583
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
19 $140 $553
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
15 $63 $260
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$127,038
Total received (2018-2024)
Avg $18,148/year across 7 years
Top 8% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
205
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,317
2023
$2,520
2022
$15,097
2021
$32,241
2020
$17,960
2019
$19,255
2018
$28,649

Payments by company (2024)

Bayer Healthcare Pharmaceuticals Inc.
$6,605
Astellas Pharma Global Development
$2,102
Janssen Scientific Affairs, LLC
$818
PFIZER INC.
$252
Daiichi Sankyo Inc.
$190
ABBVIE INC.
$167
Janssen Biotech, Inc.
$133
AstraZeneca Pharmaceuticals LP
$97
Celgene Corporation
$66
TAIHO ONCOLOGY, INC.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$58
Merck Sharp & Dohme LLC
$52
Novartis Pharmaceuticals Corporation
$49
SERVIER PHARMACEUTICALS LLC
$48
Sumitomo Pharma America, Inc.
$48
GENZYME CORPORATION
$48
EMD Serono, Inc.
$42
SpringWorks Therapeutics, Inc.
$40
Lilly USA, LLC
$40
E.R. Squibb & Sons, L.L.C.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Astellas Pharma US Inc
$27
Aveo Pharmaceuticals, Inc.
$27
Gilead Sciences, Inc.
$26
Eisai Inc.
$25
JAZZ PHARMACEUTICALS INC.
$24
ARRAY BIOPHARMA INC
$23
Genmab U.S., Inc.
$21
Genentech USA, Inc.
$20
BeiGene USA, Inc.
$20
Adaptive Biotechnologies Corporation
$20
Mirati Therapeutics, Inc.
$19
SOBI, INC
$18
Incyte Corporation
$17
Exelixis Inc.
$16
GlaxoSmithKline, LLC.
$16
Blueprint Medicines Corporation
$14
Top 3 companies account for 84.2% of 2024 payments
All-time payments by company (2018-2024) ›
Seagen Inc.
$20,918
Regeneron Healthcare Solutions, Inc.
$20,249
GENZYME CORPORATION
$18,165
AstraZeneca Pharmaceuticals LP
$9,463
Eli Lilly and Company
$8,350
Bayer Healthcare Pharmaceuticals Inc.
$6,605
Novartis Pharmaceuticals Corporation
$6,344
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,135
Exelixis Inc.
$5,857
Eisai Inc.
$3,946
Gilead Sciences, Inc.
$2,596
Myovant Sciences Inc.
$2,560
Heron Therapeutics, Inc.
$2,296
Astellas Pharma Global Development
$2,102
Bayer HealthCare Pharmaceuticals Inc.
$1,581
Aveo Pharmaceuticals, Inc.
$1,527
Dendreon Pharmaceuticals LLC
$1,517
Epizyme, Inc.,
$1,269
Janssen Biotech, Inc.
$1,238
Astellas Pharma US Inc
$1,235
Janssen Scientific Affairs, LLC
$818
EISAI INC.
$726
PFIZER INC.
$252
Daiichi Sankyo Inc.
$190
Takeda Pharmaceuticals U.S.A., Inc.
$183
ABBVIE INC.
$167
Janssen Products, LP
$85
Celgene Corporation
$66
TAIHO ONCOLOGY, INC.
$65
Merck Sharp & Dohme LLC
$52
SERVIER PHARMACEUTICALS LLC
$48
Sumitomo Pharma America, Inc.
$48
EMD Serono, Inc.
$42
SpringWorks Therapeutics, Inc.
$40
Lilly USA, LLC
$40
E.R. Squibb & Sons, L.L.C.
$38
JAZZ PHARMACEUTICALS INC.
$24
ARRAY BIOPHARMA INC
$23
Genmab U.S., Inc.
$21
Genentech USA, Inc.
$20
BeiGene USA, Inc.
$20
Adaptive Biotechnologies Corporation
$20
Mirati Therapeutics, Inc.
$19
SOBI, INC
$18
Incyte Corporation
$17
GlaxoSmithKline, LLC.
$16
Merck Sharp & Dohme Corporation
$16
Blueprint Medicines Corporation
$14
Top 3 companies account for 46.7% of all-time payments
Associated products mentioned in payments ›
AKEEGA · AYVAKIT · CABOMETYX · CINVANTI · Cabometyx · DARZALEX · DOPTELET · ELAHERE · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · FOTIVDA · GILOTRIF · IBRANCE · ICLUSIG · IDHIFA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · NINLARO · Nubeqa · OGSIVEO · OPDIVO · ORGOVYX · PADCEV · PLUVICTO · PROVENGE · Padcev · REBLOZYL · RYBREVANT · SARCLISA · TAGRISSO · TAZVERIK · TEVIMBRA · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XTANDI · Xofigo · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Miami Beach?
Compare hematology & oncology specialists in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
181
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bastos is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bastos experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bastos performed 380 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bastos receive payments from pharmaceutical companies?
Yes. Dr. Bastos received a total of $127,038 from 48 companies across 205 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bastos's costs compare to other hematology & oncology specialists in Miami Beach?
Dr. Bastos's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bastos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →